(BTAI) BioXcel Therapeutics - Performance -95.8% in 12m
Compare BTAI with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-93.11%
#190 in Group
Rel. Strength
0.53%
#7915 in Universe
Total Return 12m
-95.77%
#198 in Group
Total Return 5y
-99.80%
#192 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -88.49%
(?) Percentile in Group
12m Total Return: BTAI (-95.8%) vs XBI (-11.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
9.32% | 17.6% | 174% | 12.4 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.15% | 32% | 48.9% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-6.52% | -8.21% | 34.6% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
8.27% | 11.5% | 33.2% | 65.7 | 36 | 1.31 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.35% | 22.3% | -1.74% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
26.9% | -11.6% | 7.86% | 39.2 | 23.6 | 0.27 | 18.7% | -34.3% |
KMDA NASDAQ Kamada |
8.6% | 26% | -5.07% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
ERF PA Eurofins Scientific SE |
14.1% | 0.03% | 8.57% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BTAI vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BTAI
Total Return (including Dividends) | BTAI | XBI | S&P 500 |
---|---|---|---|
1 Month | -22.92% | 3.80% | 8.14% |
3 Months | -47.33% | -11.69% | -3.09% |
12 Months | -95.77% | -11.47% | 13.34% |
5 Years | -99.80% | -19.52% | 120.03% |
Trend Score (consistency of price movement) | BTAI | XBI | S&P 500 |
1 Month | -55.5% | 48.1% | 90.1% |
3 Months | -73.1% | -81% | -66.3% |
12 Months | -97.0% | -54.5% | 48.9% |
5 Years | -94.1% | -53.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #171 | -25.7% | -28.7% |
3 Month | #196 | -40.4% | -45.7% |
12 Month | #199 | -95.2% | -96.3% |
5 Years | #192 | -99.8% | -99.9% |
FAQs
Does BTAI BioXcel Therapeutics outperforms the market?
No,
over the last 12 months BTAI made -95.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.47%.
Over the last 3 months BTAI made -47.33%, while XBI made -11.69%.
Over the last 3 months BTAI made -47.33%, while XBI made -11.69%.
Performance Comparison BTAI vs Indeces and Sectors
BTAI vs. Indices BTAI is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -16.9% | -31.1% | -84.4% | -109% |
US NASDAQ 100 | QQQ | -18.0% | -33.9% | -85.4% | -111% |
US Dow Jones Industrial 30 | DIA | -16.4% | -27.6% | -83.4% | -105% |
German DAX 40 | DAX | -14.4% | -35.2% | -110% | -121% |
Shanghai Shenzhen CSI 300 | CSI 300 | -16.4% | -28.7% | -84.3% | -105% |
Hongkong Hang Seng | HSI | -18.5% | -37.3% | -95.4% | -106% |
India NIFTY 50 | INDA | -13.5% | -29.4% | -87.8% | -102% |
Brasil Bovespa | EWZ | -16.4% | -32.8% | -90.0% | -89.3% |
BTAI vs. Sectors BTAI is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -15.0% | -30.9% | -88.8% | -119% |
Consumer Discretionary | XLY | -20.1% | -34.6% | -84.7% | -116% |
Consumer Staples | XLP | -12.9% | -22.1% | -87.9% | -103% |
Energy | XLE | -18.5% | -29.8% | -77.8% | -89.1% |
Financial | XLF | -16.3% | -30.8% | -89.2% | -120% |
Health Care | XLV | -11.9% | -21.1% | -79.2% | -92.1% |
Industrial | XLI | -17.7% | -33.4% | -85.7% | -110% |
Materials | XLB | -16.1% | -29.1% | -80.6% | -91.9% |
Real Estate | XLRE | -12.9% | -27.6% | -84.7% | -109% |
Technology | XLK | -19.1% | -36.7% | -82.8% | -107% |
Utilities | XLU | -13.7% | -25.6% | -89.3% | -111% |
Aerospace & Defense | XAR | -15.4% | -32.8% | -93.0% | -124% |
Biotech | XBI | -9.58% | -26.7% | -65.1% | -84.3% |
Homebuilder | XHB | -17.9% | -32.8% | -73.4% | -91.1% |
Retail | XRT | -19.6% | -34.6% | -80.7% | -95.1% |